The race for COVID-19 vaccines won’t be the last vaccine race we’ll see. Vaccines for HIV are in the pipeline, scientists continue to work toward the elusive universal flu vaccine, and novel viruses we haven’t yet seen are likely in our future.
But the race for a COVID-19 vaccine has been a sprint compared to the marathon style of past vaccine development.
What does that mean for journalists covering development of the COVID-19 vaccine? How does this process differ from past ones, and what lessons and technologies might be applied to future vaccine efforts? How will society react when future vaccines become available?
The speakers from this recorded panel, at AHCJ’s Summit on Infectious Disease in November, use their expertise in respiratory virus vaccine development, vaccine decision-making and public response to vaccines to provide insight and ideas for stories you can pursue in coming months of the pandemic and even beyond.
The panelists are:
- Emily K. Brunson, Ph.D., associate professor of anthropology, Texas State University
- Ruth Karron , M.D., director, Center for Immunization Research; professor of international health, Johns Hopkins University Bloomberg School of Public Health
- Moderator: Tara Haelle, AHCJ topic leader/medical studies